Nimish Shah

Nimish Shah has extensive experience in various roles within the healthcare and finance industries. Nimish started their career as a Medical Information Associate at Novartis Pharmaceuticals in 2002 and worked there until 2003. In 2004, they interned as an Outcomes Research Intern at Pfizer. Nimish then joined Campbell Alliance as a Senior Consultant from 2006 to 2007. Following this, they worked as a Research Analyst at Credit Suisse from 2007 to 2010, specializing in equity research for specialty and generic pharmaceutical companies. Nimish later joined Citadel LLC as a Research Analyst from 2010 to 2013. In 2013, they became a Partner at Venrock, a venture capital firm. Most recently, in 2021, they co-founded Apogee Therapeutics and currently serves as a Board Director.

Nimish Shah pursued their education in a sequential manner, starting with their Bachelor of Science degree in Pharmacy from Rutgers College of Pharmacy - New Brunswick. Nimish attended the college from 1996 to 2001.

After completing their undergraduate studies, Nimish Shah enrolled at the Columbia University Mailman School of Public Health in 2003 to pursue a Master of Public Health (MPH) degree with a specialization in Health Economics. Nimish successfully completed the program in 2006.

Simultaneously, from 2004 to 2006, Nimish Shah also attended the Columbia Business School to pursue a Master of Business Administration (MBA). However, the field of study for their MBA is not provided in the information.

In summary, Nimish Shah's educational journey included a Bachelor of Science in Pharmacy, followed by a Master of Public Health with a specialization in Health Economics, and finally concluded with a Master of Business Administration.